The US Food and Drug Administration has approved Vyloy (zolbetuximab-clzb), a claudin 18.2 (CLDN18.2)-directed cytolytic ...

Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...

VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...

Recent health news includes FDA's approval of Astellas' gastric cancer therapy, the resignation of CVS Health CEO Karen Lynch ...

The FDA approved Astellas' gastric cancer therapy. CVS Health CEO Karen Lynch steps down amid shareholder pressure, with ...

Natalia Morari once reported on corrupt business in Moldova. Now she has upset many by having a son with a tycoon accused of corruption, and running against the pro-West president in elections ...

ABC NEWS features continuous, commercial-free coverage of major breaking stories in Australia and around the world. Watch all your favourite ABC programs on ABC iview. More from ABC We acknowledge ...

© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.